President Donald Trump is expected to make an announcement on Friday about lowering U.S. drug prices, according to a White House official who declined to provide additional details. The announcement is with Britain-based AstraZeneca for a "most-favored-nation" drug pricing model aimed at making prescription medicines more affordable,

Take, for example, the fact that after months of dismal jobs numbers and recession predictions, a recent White House press release touted the U.S. Bureau of Economic Analysis’ revision of second quarter GDP numbers as “explosive growth” for the economy — along with positive reactions from various financial experts.

House Speaker Mike Johnson (R-La.) rejected voting on a standalone bill to fund US military members’ salaries Wednesday, as the federal government shutdown entered its second week.

Tennessee state Rep. Justin Pearson will challenge long-time Rep. Steve Cohen in a Democratic House primary set for August of 2026.

The stakes are high, because Democrats need to gain just three seats in the 2026 elections to take control of the House, which would allow them to impede Trump’s agenda.

“San Jose ranks as the most expensive housing market, with homes averaging nearly $1.43 million,” the study noted. “Other California cities—San Francisco, San Diego, and Los Angeles—dominate the top of the list, reflecting the state’s ongoing housing affordability challenges.”

University of North Dakota Turning Point USA Secretary Jaden Cota joins 'Fox & Friends' to discuss the continued increase of enrollment to the organization in what is colloquially known as the 'Charlie Kirk effect.

Voting opened statewide Monday on whether to dramatically reshape California’s congressional districts to add as many as five Democrat-held seats in Congress — a possible offset to President Donald Trump’s moves in Texas and elsewhere to help Republicans in the 2026 election.

President Donald Trump unveiled a deal with UK-based drugmaker AstraZeneca on Friday under which the company will sell some medicines at a discount to the government's Medicaid health plan, similar to a drug pricing pact reached last week with Pfizer.